相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family
Maria E. Conidi et al.
NEUROLOGY (2015)
Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease
Marcella Catania et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Genetics of Alzheimer's Disease and Frontotemporal Dementia
B. Nacmias et al.
CURRENT MOLECULAR MEDICINE (2014)
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine
Peter D. Stenson et al.
HUMAN GENETICS (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population
Marco Monaco et al.
NEUROLOGICAL SCIENCES (2013)
Locus-specific mutation databases for neurodegenerative brain diseases
Marc Cruts et al.
HUMAN MUTATION (2012)
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Michael Scholl et al.
NEUROLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Clinical amyloid imaging in Alzheimer's disease
Karl Herholz et al.
LANCET NEUROLOGY (2011)
Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
Rita Joao Guerreiro et al.
NEUROBIOLOGY OF AGING (2010)
Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease
Nigel J. Cairns et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
AβPP A713T Mutation in Late Onset Alzheimer's Disease with Cerebrovascular Lesions
Livia Bernardi et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
A new amyloid μ variant favoring oligomerization in Alzheimer's-type dementia
Takami Tomiyama et al.
ANNALS OF NEUROLOGY (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
The Frontal Assessment Battery (FAB): Normative values in an Italian population sample
I Appollonio et al.
NEUROLOGICAL SCIENCES (2005)
A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene
G Rossi et al.
NEUROLOGY (2004)
Familial Alzheimer disease associated with A713T mutation in APP
J Armstrong et al.
NEUROSCIENCE LETTERS (2004)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Rey-Osterrieth complex figure: normative values in an Italian population sample
P Caffarra et al.
NEUROLOGICAL SCIENCES (2002)
分享论文
